A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome
Primary Purpose
Tourette Syndrome
Status
Completed
Phase
Phase 2
Locations
United Kingdom
Study Type
Interventional
Intervention
Bilateral GPi Deep Brain Stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Tourette Syndrome
Eligibility Criteria
Inclusion Criteria:
- The participant must be adult with stable Tourette syndrome.
- The participant must have a chronic and severe tic disorder with severe functional impairment, with a Yale Tourette Severity Scale score of at least 35/55 for at least 12 months prior to surgery.
- The participant must have failed conventional medical treatment at therapeutic doses of three classes of medication.
- The participant must not be suitable for behavioural intervention or that this intervention is inappropriate or unsuccessful.
- The participant must have been on stable and optimised treatment of co-morbid conditions for at least 6 months.
- The participant must be actively involved with and compliant with any psychosocial interventions.
- The patient must be compliant with treatment plans.
Exclusion Criteria:
- The tic disorder is attributable to any other condition.
- Any other medical or psychiatric disorders that substantially increase the risk of a failed procedure or that would significantly impede recovery.
- Psychosocial factors which might impede operative and post-operative care and research participation.
- Coagulation problems
- Other disease compromising life expectancy
- Patient likely to benefit from psychological intervention
- Patient unwilling to co-operate with post operative assessment and care
- Pregnancy.
- Participant under 20 years old.
Sites / Locations
- UCL Institute of Neurology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
DBS Off first
DBS On First
Arm Description
Outcomes
Primary Outcome Measures
Change in Yale Global Tic Severity Scale
The Change in Scores on the Yale Global Tic Severity Scale will be compared between defined periods with stimulation switched ON v stimulation switched OFF.
Secondary Outcome Measures
Change in Modified Rush Video Rating scale
Change in Yale Brown Obsessive Compulsive Scale
Change in Neuropsychiatric Inventory
Change in Tourette Quality of life scale
Change in MOVES scale
Change in Beck Depression Inventory
Full Information
NCT ID
NCT01647269
First Posted
July 16, 2012
Last Updated
March 18, 2015
Sponsor
University College, London
1. Study Identification
Unique Protocol Identification Number
NCT01647269
Brief Title
A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome
Official Title
A Randomised, Controlled, Crossover Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Severe Tourette Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College, London
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate whether deep brain stimulation (DBS) of the globus pallidus internum (GPi) can alleviate tics in Gilles de la Tourette syndrome (GTS) and whether this treatment has any influence on social, psychological and behavioral disability and quality of life.
Detailed Description
This study is aimed at adults who have severe Tourette syndrome and who have found that conventional treatments, such as drugs, do not control their symptoms sufficiently or cannot be tolerated.
The first two clinic visits will involve assessments. Participants will fill in a number of questionnaires and be examined by a psychiatrist and a neurologist. At the second visit, the patient will provide consent for participation and will undergo formal tests to find out if the participant is suitable and willing to undergo the research study and to record the type and severity of their Tourette syndrome symptoms.
The third visit will be an admission to hospital to have the deep brain stimulation (DBS) devices implanted. The admission to hospital should be around five days in duration.
At the first post operative follow-up visit, the patient will be placed into a "stimulator on" group or a "stimulator off" group. To try and make sure that these groups are the same to start with, each patient is put into a group by chance (randomly). This visit will take place around six weeks after surgery. In this trial, the participant will have an equal chance of being in the "on" or the "off" group first. This trial is also a "blinded" trial, neither the patient nor the researchers performing the assessments will know which group the patient is in.
At the next visit, 3 months later, the patient will have a further assessment. If their stimulators have been "on" for the first 3 months, they will be switched off. If they have been "off" they will be switched on.
At the next visit, 3 months later, the patient will be assessed again and then given the opportunity to carry on the trial with the stimulators switched on for long term follow up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tourette Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
DBS Off first
Arm Type
Experimental
Arm Title
DBS On First
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Bilateral GPi Deep Brain Stimulation
Intervention Description
Bilateral GPi Deep Brain Stimulation
Primary Outcome Measure Information:
Title
Change in Yale Global Tic Severity Scale
Description
The Change in Scores on the Yale Global Tic Severity Scale will be compared between defined periods with stimulation switched ON v stimulation switched OFF.
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Secondary Outcome Measure Information:
Title
Change in Modified Rush Video Rating scale
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Title
Change in Yale Brown Obsessive Compulsive Scale
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Title
Change in Neuropsychiatric Inventory
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Title
Change in Tourette Quality of life scale
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Title
Change in MOVES scale
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
Title
Change in Beck Depression Inventory
Time Frame
Three months after stimulation switched ON v three months after stimulation switched OFF
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The participant must be adult with stable Tourette syndrome.
The participant must have a chronic and severe tic disorder with severe functional impairment, with a Yale Tourette Severity Scale score of at least 35/55 for at least 12 months prior to surgery.
The participant must have failed conventional medical treatment at therapeutic doses of three classes of medication.
The participant must not be suitable for behavioural intervention or that this intervention is inappropriate or unsuccessful.
The participant must have been on stable and optimised treatment of co-morbid conditions for at least 6 months.
The participant must be actively involved with and compliant with any psychosocial interventions.
The patient must be compliant with treatment plans.
Exclusion Criteria:
The tic disorder is attributable to any other condition.
Any other medical or psychiatric disorders that substantially increase the risk of a failed procedure or that would significantly impede recovery.
Psychosocial factors which might impede operative and post-operative care and research participation.
Coagulation problems
Other disease compromising life expectancy
Patient likely to benefit from psychological intervention
Patient unwilling to co-operate with post operative assessment and care
Pregnancy.
Participant under 20 years old.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Foltynie, MBBS PhD
Organizational Affiliation
UCL Institute of Neurology
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCL Institute of Neurology
City
London
Country
United Kingdom
12. IPD Sharing Statement
Citations:
PubMed Identifier
25882029
Citation
Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M, Akram H, Hyam J, Clayton J, Kass-Iliyya L, Silverdale M, Evans J, Limousin P, Hariz M, Joyce E, Foltynie T. Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial. Lancet Neurol. 2015 Jun;14(6):595-605. doi: 10.1016/S1474-4422(15)00008-3. Epub 2015 Apr 14.
Results Reference
derived
Learn more about this trial
A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome
We'll reach out to this number within 24 hrs